GLOBE-NEWSWIRE

Zenas BioPharma annonce la publication d’une étude de phase 2 sur l’obéxélimab, un traitement expérimental pour la maladie liée aux IgG4 (ML-IgG4), dans The Lancet Rheumatology

L’étude a montré que l’obéxélimab produisait une amélioration clinique rapide, forte et soutenue, y compris une rémission clinique complète, chez la plupart des patients atteints de ML-IgG4 active Les résultats soutiennent la poursuite du développement de l’obéxélimab pour le traitement de la ML-IgG4 et potentiellement d’autres maladies auto-immunes à médiation

Zenas BioPharma Publica Fase 2 do Estudo Clínico do Obexelimabe, um Tratamento Investigativo da Doença Relacionada à IgG4 (IgG4-RD), no The Lancet Rheumatology

Estudo revelou que o obexelimabe produziu melhora clínica rápida, forte e sustentada, incluindo remissão clínica completa, na maioria dos pacientes com IgG4-RD ativa Os resultados apoiam o desenvolvimento contínuo do obexelimabe para o tratamento de IgG4-RD e potencialmente outras condições autoimunes mediadas por células B WALTHAM, Mass., Aug. 02, 2023

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a

Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials

Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis, and polymerization. The monomer and the polymer are 100% renewable carbon,

WATKINS WELLNESS EXPANDS INTO SAUNA CATEGORY THROUGH THE ACQUISITION OF SAUNA360

Vista, California, July 31, 2023 (GLOBE NEWSWIRE) — Watkins Wellness, a leader in hot tubs and aquatic fitness systems, today announced the expansion of its portfolio of personal well-being products and entry into the sauna category as a result of the pending acquisition of Sauna360 Group Oy (“Sauna360”) by Watkins

Presidente do Avia Solutions Group, Gediminas Ziemelis: O desafio entre os cargueiros de fábrica e as aeronaves de passageiros convertidas em cargueiros (P2F)

DUBLIN, Irlanda, July 30, 2023 (GLOBE NEWSWIRE) — Os anos de pandemia trouxeram receitas sem precedentes do transporte aéreo de cargas. Com a oferta limitada devido à paralisação dos aviões de passageiros e a demanda em alta graças ao crescimento do comércio eletrônico, os preços por quilograma de carga dispararam.

Hitachi Energy selected as preferred technology provider for the longest HVDC link in the UK

HVDC interconnection to secure power transmission and support new renewable electricity generation with the country’s largest electricity transmission project Zurich, Switzerland, July 26, 2023 (GLOBE NEWSWIRE) — Hitachi Energy, a global technology leader that is advancing a sustainable energy future for all, today announced it has been selected as preferred

Curia expande sua capacidade biológica com acesso ao DNA doggybone da Touchlight

Curia colabora com a Touchlight para expandir sua oferta de produção de mRNA para permitir o acesso ao DNA enzimático de doggybone (dbDNA™) ALBANY, N.Y. e HAMPTON, Reino Unido, July 25, 2023 (GLOBE NEWSWIRE) — A Curia, uma organização líder em contratação de pesquisa, desenvolvimento e fabricação, e a Touchlight,

Recent Posts